CHRM3 and central nervous system cancer: Figure 1A shows neutrophil infiltration and samples from GBM patients with higher CHRM3 expression (p = 0.029), indicating significantly lower patient survival. Association between overall CHRM expression and higher neutrophil infiltration in low grade glioma (LGG) also showed reduced patient survival (Supplementary Figure S1A).